Citius Pharmaceuticals (CTXR) Inventory Average (2024 - 2026)
Citius Pharmaceuticals' (CTXR) quarterly Inventory Average came in at $22.6 million in Q1 2026, up 52.42% YoY from $14.9 million in Q1 2025, and up 0.83% on a QoQ basis from $22.5 million in Q4 2025.
Citius Pharmaceuticals (CTXR) Inventory Average (2024 - 2026) Analysis & Trends
Citius Pharmaceuticals (CTXR) has 3 years of Inventory Average data on file, last reported at $22.6 million in Q1 2026.
- Quarterly Inventory Average rose 52.42% year-over-year to $22.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.6 million (up 52.42% YoY) and the FY2025 annual result came in at $15.3 million, changed N/A from the prior year.
- Inventory Average grew to $22.6 million in Q1 2026, from $22.5 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $22.6 million in Q1 2026 to a low of $11.3 million in Q4 2024.
- A 3-year average of $17.9 million and a median of $18.0 million in 2025 frame the typical range for Inventory Average.
- Annual changes were most pronounced in 2025 — Inventory Average surged 98.35% — and 2026, when it surged 52.42%.
- Tracing CTXR's Inventory Average over 3 years: stood at $11.3 million in 2024, then surged by 98.35% to $22.5 million in 2025, then increased by 0.83% to $22.6 million in 2026.
- The last three Inventory Average figures came in at $22.6 million (Q1 2026), $22.5 million (Q4 2025), and $19.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.93 Bn | 131.07 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.92 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.86 Bn | 53.72 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn | 90.57 Mn |
| 7 | BioNTech SE | 27.88 Bn | 9.49 Bn | 668.28 Mn | 196.36 Mn |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 137.65 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.51 Bn | - | - |
| 10 | Citius Pharmaceuticals | 15.88 Mn | 15.88 Mn | 1.00 Mn | 22.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.65 Mn |
| Dec 31, 2025 | 22.46 Mn |
| Sep 30, 2025 | 19.75 Mn |
| Jun 30, 2025 | 16.27 Mn |
| Mar 31, 2025 | 14.86 Mn |
| Dec 31, 2024 | 11.33 Mn |